1,5-anhydroglucitol has been researched along with Fasting Hypoglycemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadowaki, T; Muto, S; Ouchi, Y; Seino, Y; Shimazaki, R | 1 |
| Araki, E; Furukawa, N; Goto, R; Ichimori, S; Iwashita, S; Kawashima, J; Kondo, T; Maeda, T; Matsumura, T; Matsuo, T; Matsuo, Y; Motoshima, H; Nishida, K; Sekigami, T; Shimoda, S | 1 |
| Aoki, C; Aso, Y; Kato, K; Niitani, M; Suzuki, K; Tanaka, S; Tomotsune, T | 1 |
| Brown, Z; Gooley, TA; Hirsch, IB; Wright, LA | 1 |
| Baumgartner, A; Chan, CL; Kelsey, MM; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| Keers, JC; Kerstens, MN; Kreugel, G; Wolffenbuttel, BH | 1 |
| Honma, A; Koyama, T; Miyamae, Y; Ogawa, A; Shigemori, H; Yazawa, K | 1 |
| Foo, JP; Mantzoros, CS | 1 |
| Hamaguchi, T; Katsuno, T; Konishi, K; Kusunoki, Y; Miuchi, M; Miyagawa, J; Murai, K; Nagai, E; Namba, M; Ochi, F; Tokuda, M | 1 |
| Arakaki, RF; Buse, JB; Dungan, KM; Fahrbach, JL; Herman, WH; Jacobson, JG; Jiang, HH | 1 |
| Yamanouchi, T | 1 |
1 review(s) available for 1,5-anhydroglucitol and Fasting Hypoglycemia
| Article | Year |
|---|---|
[1,5-Anhydroglucitol (1,5AG)].
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Gas Chromatography-Mass Spectrometry; Humans; Hypoglycemia; Reference Standards; Sensitivity and Specificity | 1998 |
4 trial(s) available for 1,5-anhydroglucitol and Fasting Hypoglycemia
| Article | Year |
|---|---|
Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.
Topics: Adamantane; Aged; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Placebo Effect; Treatment Outcome | 2017 |
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Topics: Aged; Asian People; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
Topics: Aged; Body Mass Index; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Materials Testing; Middle Aged; Needles; Netherlands; Obesity; Patient Preference; Practice Guidelines as Topic; Self Administration | 2011 |
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Serum Albumin; Weight Loss; Young Adult | 2011 |
6 other study(ies) available for 1,5-anhydroglucitol and Fasting Hypoglycemia
| Article | Year |
|---|---|
Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy.
Topics: Aged; C-Reactive Protein; Combined Modality Therapy; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Monitoring, Ambulatory; Pilot Projects; Prospective Studies; Pyrazoles; Serum Albumin; Thiazolidines | 2014 |
1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES.
Topics: Adult; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Male; Pregnancy; Pregnancy Complications | 2015 |
Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Topics: Adolescent; Area Under Curve; Biomarkers; Blood Glucose; Child; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Monitoring, Ambulatory; Prediabetic State; Reproducibility of Results; Serum Albumin | 2017 |
Pycnalin, a new α-glucosidase inhibitor from Acer pycnanthum.
Topics: Acer; Biphenyl Compounds; Deoxyglucose; Enzyme Inhibitors; Free Radical Scavengers; Gallic Acid; Glycoside Hydrolase Inhibitors; Glycosides; Humans; Hypoglycemia; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Picrates; Plant Extracts; Sorbitol | 2011 |
The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tribulations.
Topics: Animals; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Predictive Value of Tests; Serum Albumin | 2011 |
Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Glargine; Insulin Lispro; Insulin, Long-Acting; Male; Middle Aged; Treatment Outcome; Weight Gain | 2012 |